Abbott Laboratories (NYSE: ABT) is a diversified healthcare company that develops, manufactures, and sells pharmaceuticals, medical devices, diagnostics, and nutritional products. Revenue is generated through product sales across multiple segments spanning branded prescription drugs, over-the-counter treatments, and medical technologies. The pharmaceutical portfolio includes gastroenterology brands such as Creon for pancreatic exocrine insufficiency, women's health products including Duphaston and Femoston, cardiovascular and metabolic treatments including Synthroid for hypothyroidism and TriCor for dyslipidemia, pain and central nervous system drugs including Brufen and Serc, respiratory drugs and vaccines including the clarithromycin franchise (Klacid, Claribid, Klaricid) and the Influvac influenza vaccine, and biologic products. Abbott is incorporated in Illinois, listed on the NYSE, and files annually with the SEC. The 10-K filed 2026-02-20 (accession 000162828026010185) covers the fiscal year ended December 31, 2025.

Revenue model

Product sales across pharmaceutical, medical device, diagnostics, and nutritional segments. Revenue is transactional, generated by selling branded and generic prescription drugs, vaccines, biologics, and related healthcare products to patients, hospitals, and healthcare systems.

Products and services

Gastroenterology: Creon (pancreatic exocrine insufficiency), Duphalac (colon regulation), Heptral/Transmetil/Samyr (intrahepatic cholestasis), Duspatal/Dicetel (irritable bowel syndrome). Women's health: Duphaston (gynecological disorders), Femoston (hormone replacement therapy). Cardiovascular and metabolic: Synthroid (hypothyroidism), TriCor/Lipanthyl (dyslipidemia), Omacor (hypertriglyceridemia), Physiotens (hypertension). Pain and CNS: Brufen (pain, fever, inflammation), Serc (Ménière's disease, vestibular vertigo), Sevedol (severe migraines). Respiratory and vaccines: Klacid/Claribid/Klaricid (clarithromycin, anti-infective), Influvac (influenza vaccine). Biologics: disclosed in filing but detail not fully excerpted.

Customers and end markets

Patients and healthcare providers across gastroenterology, women's health, cardiovascular, metabolic, pain management, respiratory, and infectious disease end markets. Distribution through hospitals, pharmacies, and healthcare systems.

Value-chain role

Branded pharmaceutical and healthcare product manufacturer and marketer. Develops, manufactures, and distributes finished drug products and vaccines directly to healthcare channels.

Geographic exposure

Multinational operations. Incorporated in Illinois and listed on the NYSE. Specific country or regional revenue breakdowns not supported by the provided filing excerpts.

Source: SEC 10-K, filed 2026-02-20

Industry: Pharmaceutical Preparations Peers: Baxter International Inc Becton Dickinson and Co Boston Scientific Corp Edwards Lifesciences Corp Dexcom Inc IDEXX Laboratories Inc Intuitive Surgical Inc Resmed Inc Stryker Corp